Vancomycin-Resistant Enterococci (VRE) Infections
Surveillance results: 2015-2016

From April 1, 2015, to March 31, 2016, 89 healthcare facilities took part in the surveillance of healthcare-associated vancomycin-resistant enterococci (VRE) infections, for a combined total of 4,833,086 patient days (Table 1). In total, 78 VRE infections were reported among patients who contracted strain during a current or previous hospital stay in the reporting facility (categories 1a and 1b). The incidence rate of healthcare-associated VRE infection (cat. 1a and 1b) was 0.16 per 10,000 patient days. This incidence rate was stable since 2014-2015. The acquisition rate of healthcare-associated VRE colonization (cat. 1a and 1b) in 2015-2016 was 9.76 per 10,000 patient days. For all results, only facilities that participated in at least 11 periods are included in the analyzes. Data was extracted on May 31st, 2016.

Updated : February 28, 2017
Version française

Table 1 – Participation of Healthcare Facilities in the Surveillance of VRE Infections, Québec, 2011–2012 to 2015-2016

 

2011-2012*

2012-2013

2013-2014¥

2014-2015

2015-2016

Participating facilities (N)

89

89

88

86

89

Admissions (N)

356,104

640,421

637,236

623,360

658,408

Inpatient days (N)

2,811,428

5,011,849

4,844,963

4,701,410

4,833,086

Cases of healthcare-associated VRE infection (cat. 1a and 1b) (N)

30

41**

86

84

78

Cases of healthcare-associated VRE colonization (cat. 1a and 1b) (N)

1,958

4,145

5,185

4,675

4,717

Infected patients (cat. 1a and 1b) (N)

 

 

84

78

73

* The data for 2011–2012 are incomplete, as surveillance was initiated on September 11, 2011.
Categories 1a and 1b refer to the acquisition of the strain, not the infection.
** The origin of acquisition of the strain is unknown in 66 cases involving patients already colonized with VRE.
¥ Since 2013-2014, VRE infections included known VRE carriers that developed infection.
Note: Colonizations included infections.

In 2015–2016, the incidence rate of healthcare-associated VRE infection (cat. 1a and 1b) was 0.16 per 10,000 patient days for healthcare facilities participating to the last year (Table 2) and was 0.16 per 10,000 patient days for healthcare facilities participating to the last five years (Table 3).  

In the health region of Montreal (06 HR), teaching healthcare facilities have a twofold higher healthcare-associated VRE infection incidence rate than non-teaching facilities (Table 2).

Table 2 – Incidence Rate and Percentile Distribution of Healthcare-Associated VRE Infection (Cat. 1a and 1b) by Type of Facility and Regional Categories, Québec, 2015–2016 (Incidence Rate per 10,000 Patient Days [95% CI])

Type of facility

Health Region

Min.

25%

50%

75%

90%

Max.

Incidence Rate

Non-teaching (N = 6)

06 HR

0

0

0

0.26

0.83

0.83

0.21 [0.09 ; 0.38]

Teaching (N = 14)

06 HR

0

0

0.22

0.59

0.85

1.18

0.46 [0.35 ; 0.59]

Non-teaching (N = 57)

Other RH

0

0

0

0

0.15

0.27

0.05 [0.02 ; 0.09]

Teaching (N = 12)

Other RH

0

0

0

0

0

0.16

0.02 [0 ; 0.05]

Total (N = 89)

 

0

0

0

0

0.27

1.18

0.16 [0.13 ; 0.20]

HR: Health region.
[I.C. 95%]: 95% confidence interval.

Table 3 – Change in Incidence Rate of Healthcare-Associated VRE Infection (Cat. 1a and 1b) by Type of Facility and Regional Category, Québec, 2011–2012 to 2015–2016 (Incidence Rate per 10,000 Patient Days [95% CI])

Type of facility

 

Incidence Rate

Health Region

2011-2012

2012-2013

2013-2014

2014-2015

2015-2016

Non-teaching (N = 5)

06 HR

0.31 [0.11 ; 0.61]

0.12 [0.03 ; 0.26]

0.15 [0.05 ; 0.31]

0.17 [0.06 ; 0.34]

0.23 [0.10 ; 0.42]

Teaching (N = 11)

06 HR

0.34 [0.21 ; 0.50]

0.29 [0.20 ; 0.40]

0.65 [0.50 ; 0.82]

0.60 [0.46 ; 0.76]

0.51 [0.38 ; 0.66]

Non-teaching (N = 55)

Other RH

0.03 [0.01 ; 0.07]

0.03 [0.01 ; 0.06]

0.02 [0.01 ; 0.04]

0.06 [0.03 ; 0.10]

0.05 [0.02 ; 0.09]

Teaching (N = 12)

Other RH

0

0

0.03 [0.01 ; 0.07]

0.03 [0.01 ; 0.07]

0.02 [0 ; 0.05]

Total (N = 83) *

 

0.11 [0.07 ; 0.15]

0.09 [0.06 ; 0.12]

0.17 [0.13 ; 0.21]

0.18 [0.14 ; 0.22]

0.16 [0.13 ; 0.20]

HR: Health region
* Data are those from facilities that participated in surveillance for at least 11 periods for each year between 2011-2012 and 2015-2016.

In total, 89 cases of VRE infection were reported: 82 (92.1%) were identified in patients who acquired VRE infection during a current hospital stay (72 patients), a previous hospital stay (6 patients) or in ambulatory care of the reporting facility (4 patients) (cat. 1a, 1b and 1c). A total of 12 cases were associated to another facility, community or unknown (cat. 2, 3 and 4) (Table 4). A total of 7 cases were associated to another facility, community and unknown (cat. 2, 3 and 4) (Table 4). Among the 89 VRE infections, 48 infections were from known colonized cases.

Table 4 – Cases of VRE Infection by Presumed Origin of Acquisition, Québec, 2015–2016 (N, %)

Category

Origin of Acquisition

Infection

1a

Healthcare-associated with a current hospital stay in the reporting facility

72 (80.9%)

1b

Healthcare-associated with a previous hospital stay in the reporting facility

6 (6.7%)

1c

Healthcare-associated with ambulatory care in the reporting facility

4 (4.5%)

1d

Healthcare-associated with long term unit in the reporting facility

0 (0%)

2

Healthcare-associated with another facility

2 (2.2%)

3

Community-associated

5 (5.6%)

4

Unknown origin

0 (0%)

 

Total

89

In 2015-2016, among 89 infections, 15 primary bloodstream infections (BSI) and 13 secondary bloodstream infections have been reported (Table 5). The number of BSI observed in 2015-2016 is decreasing as compared to 2014-2015 (N = 23).

Table 5 – Number of Cases of VRE Infection from All Origins by Type of Infection and Number of Complications (Secondary BSIs), Québec, 2015–2016 (N = 89)

Type of Infection

Infections (N)

Secondary Bloodstream Infections (N)

Primary BSI

 

   CRBSI-MBI

1

-

   CRBSI

2

-

   Non- CRBSI-MBI

0

-

   Non-CRBSI

12

-

   HD

0

-

Others

   

   Urinary tract

18

1

   Abdominal

19

7

   Pulmonary

4

0

   Surgical site

19

2

   Skin and soft tissue

10

2

   Bones and joints

0

0

   Others

4

1

Total

89

13

BSI : bloodstream infection
CRBSI : catheter-related bloodstream infection
MBI : mucosal barrier injury
Non-CRBSI : non- catheter-related primary bloodstream infection
HD: hemodialysis

A total of 16 deaths within 30 days were observed in 2015-2016, yielding a case fatality of 18.0% (Table 6). Since 2011-2012, the case fatality is stable from 18.0% to 19.2%.

Table 6 – Number of Deaths and 30-days Case Fatality Related to VRE Infections, Québec, 2011-2012 to
2015-2016

 

2011-2012

2012-2013

2013-2014

2014-2015

2015-2016

VRE infections (all origins)

63

112

99

99

89

Number of deaths

12

21

18

19

16

Case fatality

19.0%

18.8%

18.2%

19.2%

18.0%

In 2015-2016, the acquisition rate of healthcare-associated VRE colonization (cat. 1a and 1b) was 9.76 per 10,000 patient days in healthcare facilities participating at the least year of surveillance (Table 11) and was 9.60 per 10,000 patient days in those participating at the least five year of surveillance (Table 7). In the health region of Montreal (06 HR) and others, the acquisition rate of healthcare-associated VRE colonization in non-teaching facilities was higher to the one in teaching facilities (Table 7). This trend is similar to 2014-2015.

Table 7 – Change in the Number of Cases and Acquisition Rate of Healthcare-associated VRE Colonization (Cat. 1a and 1b) by Type of Facility and Regional Category, Québec, 2011-2012 to 2015-2016 (Acquisition rate of Healthcare-Associated VRE colonization per 10,000 patient days)

 

Type of Facility

 

Health Region

2011-2012

2012-2013

2013-2014

2014-2015

2015-2016

Number of cases of colonization

Acquisition Rate of HA-VRE Colonization

Number of cases of colonization

Acquisition Rate of HA-VRE

Number of cases of colonization

Acquisition Rate of HA-VRE

Number of cases of colonization

Acquisition Rate of HA-VRE

Number of cases of colonization

Acquisition Rate of HA-VRE

Non-teaching (N = 5)

06 HR

335

17.53 [15.70 ; 19.46]

668

19.24 [17.81 ; 20.73]

775

22.64 [21.07 ; 24.26]

822

23.89 [22.28 ; 25.55]

913

26.10 [24.43 ; 27.82]

Teaching (N = 11)

06 HR

894

15.11 [14.14 ; 16.12]

1 778

17.11 [16.32 ; 17.91]

1 940

19.01 [18.17 ; 19.87]

1 807

18.16 [17.33 ; 19.01]

1 999

20.83 [19.93 ; 21.75]¥

Non-teaching (N = 55)

Other RH

409

3.55 [3.21 ; 3.90]

700

3.38 [3.13 ; 3.64]

1 078

5.24 [4.93 ; 5.56]

1 661

8.03 [7.65 ; 8.42]

1 138

5.57 [5.25 ; 5.90]¥

Teaching (N = 12)

Other RH

64

0.94 [0.72 ; 1.18]

299

2.48 [2.21 ; 2.77]

488

4.12 [3.76 ; 4.49]

252

2.17 [1.91 ; 2.45]

265

2.32 [2.05 ; 2.61]

Total (N = 83)*

 

1 702

6.51 [6.20 ; 6.82]

3 445

7.39 [7.15 ; 7.64]

4 281

9.30 [9.02 ; 9.58]

4 542

9.94 [9.65 ; 10.23]

4 315

9.60 [9.32 ; 9.89]

* HR: Health region * Number of healthcare facilities participating in each of the five years of surveillance.
¥ Significant statistical difference (p ˂ 0.05) between acquisition rate of HA-VRE colonization of 2014-2015 and 2015-2016.

Table 8 shows the number of non-teaching facilities that specified the type of screening used at admission (55 out of 63) and during hospitalization (53 out of 63). The majority of teaching facilities specified the type of screening used at admission (23 out of 26) and during hospitalization (23 out of 26). Only two teaching facilities from the health region of Montreal and one from other health region did not identify the total type of screening.

Table 8 – Number of Healthcare Facilities that specified the type of Screening Procedure Used at Admission and During Hospitalization by Type of Facility and Regional Category, Québec, 2015-2016

Type of Facility

Health Region

Number of Facilities That specified the Type of Screening Procedure Used

At Admission

During Hospitalization

Not Specified

Total

Non-teaching (N = 6)

06 HR

5

5

3

6

Teaching (N = 14)

06 HR

12

12

2

12

Non-teaching (N = 57)

Other RH

50

48

22

57

Teaching (N = 12)

Other RH

11

11

1

12

Total (N = 89)

 

78

76

28

87

* The number of facilities that reported the type of screening procedures used at admission and during hospitalization is not additive.
HR: Health region.

Tables 9 and 10 feature the total number of screening tests performed at admission and during hospitalization, as well as the mean number of VRE screening tests.

Table 9 – Total Number of Screening Tests Performed at Admission and During Hospitalization by Type of Facility and Regional Category, Québec, 2015-2016

Type of Facility

Health Region

Number of screening procedure

At Admission

During Hospitalization

Not Specified

Total

Non-teaching

06 HR

21,547

23,107

3,439

48,093

Teaching

06 HR

39,053

150,682

11,257

200,992

Non-teaching

Other RH

139,289

132,228

53,542

325,059

Teaching

Other RH

67,501

75,171

24,985

167,657

Total

 

267,390

381,188

93,223

741,801

HR: Health region.

Table 10 – Mean Number of VRE Screening Score by Type of Healthcare Facility and Regional Categories, Québec, 2015-2016 (Mean VRE Screening Tests per Admission)

Type of Facility

Health Region

Mean Number of VRE Screening Score*

At Admission

During Hospitalization

Total

Non-teaching

06 HR

0.54

0.58

1.20

Teaching

06 HR

0.25

0.96

1.28

Non-teaching

Other RH

0.47

0.45

1.10

Teaching

Other RH

0.41

0.46

1.02

Total

 

0.41

0.58

1.13

 * The mean numbers of VRE screening score at admission and during hospitalization are not additive.
HR: Health region.

The incidence rate of HA-VRE infection and the percentile rankings by type of facility are shown in Figure 1 and 2. Figures 3 and 4 feature the rate of acquisition and percentile ranking of HA-VRE colonization by type of facility.

Figure 1 – Incidence Rate and Percentile Ranking of Healthcare-Associated VRE Infection (Cat. 1a and 1b) for Healthcare Facilities from the health region of Montreal, Québec, 2015-2016 (Incidence Rate per 10,000 patient days)

NB: Facilities 6, 12, 13, 34, 38, 48, 76, 80, 83 and 118 did not report any cases of infection in 2015-2016.

Figure 2 – Incidence Rate and Percentile Ranking of Healthcare-Associated VRE Infection (Cat. 1a and 1b) for Healthcare Facilities outside Heath Region of Montreal, Québec, 2015-2016 (Incidence Rate per 10,000 patient days)

NB: Facilities 2, 7, 10, 11, 15, 16, 18, 20, 23, 24, 27, 28, 30, 31, 32, 33, 37, 39, 41, 42, 44, 45, 47, 49, 51, 52, 53, 56, 58, 59, 61, 64, 65, 67, 70, 71, 72, 74, 75, 77, 81, 82, 84, 85, 86, 88, 89, 91, 95, 96, 97, 99, 100, 103, 107, 109, 111, 112, 113 and 130 did not report any cases of infection in 2015-2016.

Figure 3 – Acquisition Rate of Healthcare-Associated VRE Colonization (Cat.1a and 1b) in Healthcare Facilities from the Health Region of Montreal, Québec, 2015-2016 (Acquisition Rate of Healthcare-Associated VRE Colonization per 10,000 patient days)

NB: Facilities 6 and 12 did not report any cases of infection in 2015-2016.

Figure 4 – Acquisition Rate of Healthcare-Associated VRE Colonization (Cat.1a and 1b) in Healthcare Facilities outside Heath Region of Montreal, Québec, 2015-2016 (Acquisition Rate of Healthcare-Associated VRE Colonization per 10,000 patient days)

NB: Facilities 16, 20, 32, 49, 59, 61, 64, 67, 70, 71, 72, 74, 75, 84, 86, 88, 89, 91, 97, 100, 107, 109 and 112 did not report any cases of infection in 2015 2016.

At the local level, in 2015-2016, the incidence rate of HA-VRE infection ranged from 0 to 1.18 per 10,000 patient days, whereas the acquisition rate of HA-VRE colonization ranged from 0 to 60.23 per 10,000 patient days. A total of 25 facilities (28.1%) did not report any HA-VRE infection or colonization in 2015-2016. A detailed summary of the surveillance data for HA-VRE infection by healthcare facility can be found in Table 11.

Table 11 – Incidence Rate of Healthcare-Associated VRE Infection (cat. 1a and 1b), Acquisition Rate of Healthcare-Associated VRE Colonization and Mean VRE Screening Tests by Admission and by Facility, Québec, 2015-2016 (Incidence Rate per 10,000 patient days [95% CI]; Acquisition Rate of Colonization per 10,000 patient days)

HR

Facility

 

Incidence Rate of HA-VRE Infection (cat. 1a and 1b) [95% CI]

Acquisition Rate of HA-VRE Colonization (cat. 1a and 1b)

Mean VRE Screening Tests per Admission*

Number

Name

1

16

HÔPITAL RÉGIONAL DE RIMOUSKI

0

0

0.99

32

CENTRE HOSPITALIER RÉGIONAL DU GRAND-PORTAGE

0

0

1.04

61

HÔPITAL NOTRE-DAME-DE-FATIMA

0

0

0.31

71

HÔPITAL DE MATANE

0

0

0.89

77

HÔPITAL D'AMQUI

0

2.44

2.08

84

HÔPITAL DE NOTRE-DAME-DU-LAC

0

0

1.47

 

BAS-SAINT-LAURENT

0

0.17

1.05

2

20

HÔPITAL DE CHICOUTIMI

0

0

0.59

67

HÔPITAL ET CENTRE DE RÉADAPTATION DE JONQUIÈRE

0

0

0.72

74

HÔPITAL DE DOLBEAU-MISTASSINI

0

0

0.98

88

HÔPITAL. CLSC ET CENTRE D'HÉBERGEMENT DE ROBERVAL

0

0

0.79

100

HÔPITAL DE LA BAIE

0

0

0.76

112

HÔPITAL D'ALMA

0

0

0.44

 

SAGUENAY–LAC-SAINT-JEAN

0

0

0.64

3

2

HÔPITAL DE L'ENFANT-JÉSUS

0

0.23

1.15

7

PAVILLON L'HÔTEL-DIEU DE QUÉBEC

0

1.75

1.50

24

HÔPITAL DU SAINT-SACREMENT

0

1.00

1.29

27

PAVILLON CENTRE HOSPITALIER DE L'UNIVERSITÉ LAVAL

0

2.78

1.04

28

PAVILLON SAINT-FRANCOIS D'ASSISE

0

6.23

1.39

33

INSTITUT UNIVERSITAIRE DE CARDIOLOGIE ET DE PNEUMOLOGIE DE QUÉBEC

0

0.31

1.32

59

HÔPITAL DE BAIE-SAINT-PAUL

0

0

1.31

86

HÔPITAL DE LA MALBAIE

0

0

1.12

 

CAPITALE-NATIONALE

0

1.95

1.24

4

23

HÔTEL-DIEU D'ARTHABASKA

0

0.19

1.11

31

PAVILLON SAINTE-MARIE

0

0.64

1.23

41

HÔPITAL DU CENTRE-DE-LA-MAURICIE

0

0.85

1.13

44

HÔPITAL SAINTE-CROIX

0

3.44

1.21

85

CENTRE DE SANTÉ ET DE SERVICES SOCIAUX DU HAUT-SAINT-MAURICE

0

4.20

0.78

 

MAURICIE ET CENTRE-DU-QUÉBEC

0

1.22

1.18

5

15

HÔPITAL FLEURIMONT

0

0.19

0.32

30

HOTEL-DIEU DE SHERBROOKE

0

0.15

0.49

46

HÔPITAL DE GRANBY

0.21 [0 ; 0.82]

5.22

1.67

49

CENTRE DE SANTÉ ET DE SERVICES SOCIAUX MEMPHRÉMAGOG

0

0

0.83

75

CENTRE DE SANTÉ ET DE SERVICES SOCIAUX DU GRANIT

0

0

0.05

99

HÔPITAL BROME-MISSISQUOI-PERKINS

0

1.79

0.86

 

ESTRIE

0.04 [0 ; 0.15]

1.22

0.62

6

3

GLEN - ROYAL VICTORIA

1.18 [0.62 ; 1.91]

10.39

0.81

4

HÔPITAL NOTRE-DAME DU CHUM

0.39 [0.10 ; 0.87]

17.26

1.91

5

HÔPITAL GÉNÉRAL JUIF

0.54 [0.25 ; 0.95]

27.17

0.90

6

GLEN - ENFANTS

0

0

0.03

8

PAVILLON MAISONNEUVE/PAVILLON MARCEL-LAMOUREUX

0.85 [0.48 ; 1.32]

37.74

1.10

12

CENTRE HOSPITALIER UNIVERSITAIRE SAINTE-JUSTINE

0

0

0

13

INSTITUT DE CARDIOLOGIE DE MONTRÉAL

0

2.60

2.49

21

HÔPITAL SAINT-LUC DU CHUM

0.59 [0.21 ; 1.16]

9.39

1.55

22

HÔTEL-DIEU DU CHUM

0.29 [0.03 ; 0.83]

15.38

2.78

25

HÔPITAL DU SACRÉ-COEUR DE MONTRÉAL

0.14 [0.01 ; 0.40]

20.77

1.90

26

HÔPITAL DE VERDUN

0.26 [0.03 ; 0.74]

26.31

0.75

29

HÔPITAL GÉNÉRAL DE MONTRÉAL

0.69 [0.22 ; 1.43]

19.73

1.52

34

HÔPITAL SANTA CABRINI

0

14.91

1.39

36

HÔPITAL GÉNÉRAL DU LAKESHORE

0.83 [0.30 ; 1.63]

60.23

1.63

38

HÔPITAL JEAN-TALON

0

7.41

1.46

48

CENTRE HOSPITALIER DE ST. MARY

0

29.97

1.54

76

HOPITAL DE LACHINE

0

20.40

0

80

HÔPITAL FLEURY

0

17.46

1.86

83

HÔPITAL DE LASALLE

0

3.17

0.26

118

HÔPITAL NEUROLOGIQUE DE MONTRÉAL

0

4.51

1.28

 

MONTRÉAL

0.40 [0.31 ; 0.50]

20.43

1.26

7

39

HÔPITAL DE GATINEAU

0

1.56

0.05

40

HÔPITAL DE HULL

0.16 [0 ; 0.63]

8.95

0.24

51

HÔPITAL DE MANIWAKI

0

1.40

1.27

95

HÔPITAL DU PONTIAC

0

6.58

1.75

111

HÔPITAL DE PAPINEAU

0

13.98

1.35

 

OUTAOUAIS

0.06 [0 ; 0.23]

5.92

0.44

8

47

HÔPITAL DE ROUYN-NORANDA

0

0.40

0.37

52

HÔPITAL D'AMOS

0

1.23

0.24

65

HÔPITAL ET CLSC DE VAL-D'OR

0

4.52

0.98

70

CENTRE DE SOINS DE COURTE DURÉE LA SARRE

0

0

1.44

82

PAVILLON SAINTE-FAMILLE

0

4.00

0.74

 

ABITIBI-TÉMISCAMINGUE

0

1.96

0.66

9

64

HÔPITAL LE ROYER

0

0

0.26

72

HÔPITAL ET CENTRE D'HÉBERGEMENT DE SEPT-ÎLES

0

0

0.09

 

CÔTE-NORD

0

0

0.17

10

96

CENTRE DE SANTÉ DE CHIBOUGAMAU

0

1.34

0.60

 

NORD-DU-QUÉBEC

0

1.34

0.60

11

53

HÔPITAL DE CHANDLER

0

0.79

0.82

91

HÔPITAL HÔTEL-DIEU DE GASPÉ

0

0

0.18

97

HÔPITAL DE MARIA

0

0

1.55

107

HÔPITAL DE L'ARCHIPEL

0

0

0.51

109

HÔPITAL DE SAINTE-ANNE-DES-MONTS

0

0

0.51

 

GASPÉSIE–ÎLES-DE-LA-MADELEINE

0

0.18

0.84

12

18

HÔTEL-DIEU DE LÉVIS

0

2.41

0.69

63

HÔPITAL DE SAINT-GEORGES

0.25 [0 ; 0.99]

17.59

1.42

89

HÔPITAL DE MONTMAGNY

0

0

1.12

113

HÔPITAL DE THETFORD MINES

0

0.43

0.71

 

CHAUDIÈRE-APPALACHES

0.06 [0 ; 0.24]

5.70

0.94

13

19

HÔPITAL CITÉ DE LA SANTÉ

0.06 [0 ; 0.23]

1.93

0.81

 

LAVAL

0.06 [0 ; 0.23]

1.93

0.81

14

11

HÔPITAL PIERRE-LE GARDEUR

0

1.69

0.88

14

CENTRE HOSPITALIER RÉGIONAL DE LANAUDIÈRE

0.10 [0 ; 0.40]

5.55

1.64

 

LANAUDIÈRE

0.05 [0 ; 0.19]

3.49

1.23

15

45

HÔPITAL DE SAINT-EUSTACHE

0

2.58

1.08

56

CENTRE DE SANTÉ ET DE SERVICES SOCIAUX D'ARGENTEUIL

0

4.87

2.86

81

HÔPITAL DE MONT-LAURIER

0

13.04

1.88

101

HÔPITAL RÉGIONAL DE SAINT-JÉRÔME

0.27 [0.05 ; 0.66]

26.48

1.79

103

HÔPITAL LAURENTIEN

0

3.68

1.54

 

LAURENTIDES

0.12 [0.02 ; 0.29]

13.6

1.55

16

1

HÔPITAL CHARLES LEMOYNE

0.16 [0.02 ; 0.45]

9.52

1.35

9

HÔPITAL DU HAUT-RICHELIEU

0.24 [0.02 ; 0.69]

18.12

1.49

10

HÔPITAL PIERRE-BOUCHER

0

12.95

0.75

35

HÔPITAL HONORÉ-MERCIER

0.15 [0 ; 0.59]

8.35

1.59

37

HÔTEL-DIEU DE SOREL

0

1.33

1.81

42

CENTRE HOSPITALIER ANNA-LABERGE

0

6.89

2.39

58

HÔPITAL DU SUROÎT

0

2.31

1.33

130

HÔPITAL BARRIE MEMORIAL

0

7.92

1.56

 

MONTÉRÉGIE

0.09 [0.03 ; 0.18]

9.49

1.41

 

 

Total

0.16 [0.13 ; 0.20]

9.76

1.13

 

* Number of screening test divided by number of admisions.

Comité de surveillance provinciale des infections nosocomiales (SPIN)

Editorial committee

Christophe Garenc, Direction des risques biologiques et de la santé au travail, Institut national de santé publique du Québec

Danielle Moisan, Centre hospitalier régional du Grand-Portage

Muleka Ngenda-Muadi, Direction des risques biologiques et de la santé au travail, Institut national de santé publique du Québec

Mélissa Trudeau, Direction des risques biologiques et de la santé au travail, Institut national de santé publique du Québec

Isabelle Rocher, Direction des risques biologiques et de la santé au travail, Institut national de santé publique du Québec

Patrice Vigeant, CISSS de la Montérégie-Ouest - Hôpital du Suroît

Jasmin Villeneuve, Direction des risques biologiques et de la santé au travail, Institut national de santé publique du Québec

File Version EPUB (212.11 KB)